Attachment A2_60 Day FRN

Federal Register / Vol. 89, No. 103 / Tuesday, May 28, 2024 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request; Information
Collection Request Title: Evaluation of
the Maternal and Child Health Bureau
Pediatric Mental Health Care Access
Program and the Screening and
Treatment for Maternal Mental Health
and Substance Use Disorders Program
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:

In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects of the Paperwork Reduction Act
of 1995, HRSA announces plans to
submit an Information Collection
Request (ICR), described below, to the
Office of Management and Budget
(OMB). Prior to submitting the ICR to
OMB, HRSA seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on this ICR should be
received no later than July 29, 2024.
ADDRESSES: Submit your comments to
[email protected] or mail the HRSA
Information Collection Clearance
Officer, Room 14N39, 5600 Fishers
Lane, Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email [email protected]
or call Joella Roland, the HRSA
Information Collection Clearance
Officer, at (301) 443–3983.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the ICR title
for reference.
Information Collection Request Title:
Evaluation of the Maternal and Child
Health Bureau Pediatric Mental Health
Care Access Program and the Screening
and Treatment for Maternal Mental
Health and Substance Use Disorders
Program, OMB No. 0906–xxxx—New.
Abstract: This notice describes
information collection requests for two
of HRSA’s Maternal and Child Health
Bureau programs: the Pediatric Mental
Health Care Access (PMHCA) program
and the Screening and Treatment for
Maternal Mental Health and Substance
Use Disorders (MMHSUD) program. The

khammond on DSKJM1Z7X2PROD with NOTICES

SUMMARY:

VerDate Sep<11>2014

18:43 May 24, 2024

Jkt 262001

PMHCA program aims to promote
behavioral health integration into
pediatric primary care by developing
and supporting state, regional, and tribal
pediatric mental health care
teleconsultation access programs. The
MMHSUD program aims to support
maternity care providers and clinical
practices by supporting the
development, improvement, and/or
maintenance of statewide or regional
behavioral health networks. Both
programs support health professionals
(HPs) 1 in their delivery of high-quality
and timely screening, assessment,
treatment, and referrals for their targeted
populations (e.g., children, adolescents,
and young adults for PMHCA programs;
pregnant and postpartum people for
MMHSUD programs) through the
provision of clinical behavioral health
teleconsultation, care coordination
support/navigation (e.g., resource
identification and referrals), and
training and education. Additionally,
the PMHCA and MMHSUD programs
focus on reducing racial, ethnic, and
geographic disparities in access to care,
especially in rural and other
underserved areas.
The information will be collected
from PMHCA and MMHSUD award
recipient programs funded in 2021,
2022, or 2023 and from participants in
and stakeholders of those programs:
• The 2021 and 2022 PMHCA
programs are authorized by 42 U.S.C
254c–19 (sec. 330M of the Public Health
Service Act), using funding provided by
section 2712 of the American Rescue
Plan Act of 2021 (Pub. L. 117–2).
• The 2023 PMHCA programs are
authorized by 42 U.S.C 254c–19 (sec.
330M of the Public Health Service Act),
as amended by section 11005 of the
Bipartisan Safer Communities Act (Pub.
L. 117–159).
• The 2023 MMHSUD programs are
authorized by 42 U.S.C. 247b–13a; (sec.
317L–1 of the Public Health Service
Act).
To evaluate progress made toward the
programs’ goals, this data collection will
use the following eight instruments: (1)
HP Survey, (2) Practice-Level Survey,
(3) Program Implementation Survey, (4)
Behavioral Health Consultation Provider
Semi-Structured Interview (SSI), (5)
Care Coordinator SSI, (6) Champion SSI,
1 Health professionals may include, but are not
limited to, pediatricians, family physicians, adult
primary care clinicians, obstetrician-gynecologists,
physician assistants, advanced practice nurses/
nurse practitioners, licensed practical nurses,
registered nurses, nurse midwives, counselors,
behavioral health clinicians, social workers, care
coordinators, medical assistants, and patient care
navigators.

PO 00000

Frm 00089

Fmt 4703

Sfmt 4703

46143

(7) Community-Based and Other
Resources SSI, and (8) Program
Implementation SSI.
Need and Proposed Use of the
Information: HRSA needs this
information to evaluate the PMHCA and
MMHSUD programs to guide future
decisions regarding increasing HPs’
capacity to address patients’ behavioral
health and access to behavioral health
services. Specifically, data collected for
the evaluation will be used to study the
efforts of the PMHCA and MMHSUD
programs to achieve key outcomes (e.g.,
increase in access to behavioral health
services; HPs trained; identification of
community-based resources, including
counselors or family service providers)
and to measure whether and to what
extent awardee programs are associated
with changes in these outcomes. The
evaluation will examine changes over
time within and/or across the PMHCA
and MMHSUD programs, regarding
PMHCA- and MMHSUD-enrolled/
participating HPs’ and practices’: (1)
capacity to address patients’ behavioral
health and access to behavioral health
care, through screening, assessment,
treatment, and referral for behavioral
health conditions and (2) use of program
services (e.g., consultation, care
coordination, training).
Likely Respondents
• HP Survey: Pediatricians, family
physicians, obstetrician-gynecologists,
physician assistants, advanced practice
nurses/nurse practitioners, licensed
practical nurses, registered nurses,
counselors, social workers, medical
assistants, and patient care navigators.
• Practice-Level Survey: Practice
managers (e.g., office managers, office
leadership, nurse champions).
• Program Implementation Survey:
Cooperative agreement-funded project
directors/principal investigators.
• Behavioral Health Consultation
Provider SSI: PMHCA and MMHSUD
program-level behavioral health
consultation providers.
• Care Coordinator SSI: PMHCA- and
MMHSUD-program-level care
coordinators.
• Champion SSI: PMHCA and
MMHSUD program champions (e.g.,
HPs, community and social service
specialists).
• Community-Based and Other
Resources SSI: PMHCA and MMHSUD
program-level community resource
partner representatives (e.g., counselors,
social workers, other community and
social service specialists, other HPs/

E:\FR\FM\28MYN1.SGM

28MYN1

46144

Federal Register / Vol. 89, No. 103 / Tuesday, May 28, 2024 / Notices

support workers, practice/organization
managers).
• Program Implementation SSI:
Cooperative agreement-funded project
directors/principal investigators.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information

requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train

personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Form name

Average
burden per
response
(in hours)

Total
responses

Total burden
hours

HP Survey ............................................................................
Practice-Level Survey ..........................................................
Program Implementation Survey .........................................
Behavioral Health Consultation Provider SSI ......................
Care Coordinator SSI ..........................................................
Champion SSI ......................................................................
Community-Based and Other Resources SSI .....................
Program Implementation SSI ...............................................

23,177
6,164
66
66
66
66
50
132

1
1
1
1
1
1
1
1

23,177
6,164
66
66
66
66
50
132

0.33
0.33
0.33
0.75
0.75
0.50
0.50
1.00

7,648.41
2,034.12
21.78
49.50
49.50
33.00
25.00
132.00

Total ..............................................................................

29,787

........................

29,787

........................

9,993.31

HRSA specifically requests comments
on: (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions; (2) the accuracy of the
estimated burden; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–11567 Filed 5–24–24; 8:45 am]
BILLING CODE 4165–15–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings

khammond on DSKJM1Z7X2PROD with NOTICES

Number of
responses per
respondent

Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which

VerDate Sep<11>2014

18:43 May 24, 2024

Jkt 262001

would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Clinical Neuroplasticity and
Neurotransmitters Study Section.
Date: June 20–21, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate, 2650 Virginia
Avenue NW, Washington, DC 20037.
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892, 301–435–
1259, [email protected].
Name of Committee: Oncology 1-Basic
Translational Integrated Review Group; Gene
Regulation in Cancer Study Section.
Date: June 24–25, 2024.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: North Bethesda Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Manzoor A. Zarger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6208,
MSC 7804, Bethesda, MD 20892, (301) 435–
2477, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Medical Imaging.
Date: June 24–25, 2024.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: North Bethesda Marriott Hotel &
Conference Center, Montgomery County

PO 00000

Frm 00090

Fmt 4703

Sfmt 4703

Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Krystyna H Szymczyk,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 480–4198, szymczykk@
csr.nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Lung Injury, Repair, and Remodeling
Study Section.
Date: June 24–25, 2024.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Ghenima Dirami, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4122,
MSC 7814, Bethesda, MD 20892, 240–498–
7546, [email protected].
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Clinical Oncology Study Section.
Date: June 24–25, 2024.
Time: 8:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Hybrid Meeting).
Contact Person: Laura Asnaghi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockville Drive, Room 6200,
MSC 7804, Bethesda, MD 20892, (301) 443–
1196, [email protected]
Name of Committee: Applied Therapeutics
for Cancer Integrated Review Group;
Mechanisms of Cancer Therapeutics A Study
Section.
Date: June 24–25, 2024.

E:\FR\FM\28MYN1.SGM

28MYN1